STATE STREET CORP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 136 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 5.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$67,121,991
-16.2%
1,459,491
+4.7%
0.00%0.0%
Q2 2023$80,142,145
+57.2%
1,394,504
+2.6%
0.00%
+33.3%
Q1 2023$50,981,063
-33.0%
1,359,495
-50.0%
0.00%
+50.0%
Q4 2022$76,130,900
+76.6%
2,717,020
+77.1%
0.00%
-33.3%
Q3 2022$43,100,000
-19.6%
1,533,793
-0.5%
0.00%0.0%
Q2 2022$53,606,000
+13.0%
1,540,846
+16.6%
0.00%
+50.0%
Q1 2022$47,458,000
+41.6%
1,321,951
-8.1%
0.00%0.0%
Q4 2021$33,519,000
+20.7%
1,439,207
-1.4%
0.00%
+100.0%
Q3 2021$27,761,000
-4.4%
1,460,335
+1.4%
0.00%
-50.0%
Q2 2021$29,029,000
+12.8%
1,439,931
+2.5%
0.00%
+100.0%
Q1 2021$25,739,000
-0.3%
1,404,953
+9.5%
0.00%
-50.0%
Q4 2020$25,804,000
+6.6%
1,283,164
-0.6%
0.00%0.0%
Q3 2020$24,197,000
-14.5%
1,290,490
+2.4%
0.00%0.0%
Q2 2020$28,304,000
+59.3%
1,260,218
+5.3%
0.00%0.0%
Q1 2020$17,768,000
-17.1%
1,197,293
+7.8%
0.00%
+100.0%
Q4 2019$21,422,000
+1.2%
1,110,501
+4.0%
0.00%
-50.0%
Q3 2019$21,178,000
-8.1%
1,067,962
-2.2%
0.00%0.0%
Q2 2019$23,050,000
+6.3%
1,091,905
+2.9%
0.00%0.0%
Q1 2019$21,682,000
+7.0%
1,061,284
+4.3%
0.00%0.0%
Q4 2018$20,257,000
+0.3%
1,017,941
-3.0%
0.00%0.0%
Q3 2018$20,189,000
+31.5%
1,049,056
+4.3%
0.00%
+100.0%
Q2 2018$15,348,000
-17.1%
1,005,888
+1.8%
0.00%
-50.0%
Q1 2018$18,524,000
-1.2%
987,884
+1.4%
0.00%0.0%
Q4 2017$18,743,000
+10.1%
974,179
+2.3%
0.00%
+100.0%
Q3 2017$17,026,000
-1.6%
952,638
-1.7%
0.00%
-50.0%
Q2 2017$17,306,000
+12.3%
969,128
-8.8%
0.00%
+100.0%
Q1 2017$15,406,000
-12.5%
1,062,439
+11.1%
0.00%
-50.0%
Q4 2016$17,610,000
+3.1%
955,991
+6.2%
0.00%0.0%
Q3 2016$17,075,000
+71.4%
900,303
+45.7%
0.00%
+100.0%
Q2 2016$9,960,000
+25.3%
617,815
-6.8%
0.00%0.0%
Q1 2016$7,949,000
-12.5%
662,582
+3.8%
0.00%0.0%
Q4 2015$9,087,000
+61.9%
638,377
+33.0%
0.00%0.0%
Q3 2015$5,613,000
-12.4%
480,037
+31.6%
0.00%0.0%
Q2 2015$6,411,000
+333.5%
364,671
+268.4%
0.00%
Q1 2015$1,479,000
+71.2%
99,001
+33.1%
0.00%
Q4 2014$864,000
+13.5%
74,400
+13.8%
0.00%
Q3 2014$761,00065,4000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders